Cited 0 times in
A phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in patients with HER2-high and HER2-low gastric or gastroesophageal junction (GEJ) adenocarcinoma
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.